221 related articles for article (PubMed ID: 11967322)
1. Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins.
Sarobe P; Lasarte JJ; Casares N; López-Díaz de Cerio A; Baixeras E; Labarga P; García N; Borrás-Cuesta F; Prieto J
J Virol; 2002 May; 76(10):5062-70. PubMed ID: 11967322
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses.
Sarobe P; Lasarte JJ; Zabaleta A; Arribillaga L; Arina A; Melero I; Borrás-Cuesta F; Prieto J
J Virol; 2003 Oct; 77(20):10862-71. PubMed ID: 14512536
[TBL] [Abstract][Full Text] [Related]
3. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals.
Kanto T; Hayashi N; Takehara T; Tatsumi T; Kuzushita N; Ito A; Sasaki Y; Kasahara A; Hori M
J Immunol; 1999 May; 162(9):5584-91. PubMed ID: 10228041
[TBL] [Abstract][Full Text] [Related]
4. Induction of primary human T cell responses against hepatitis C virus-derived antigens NS3 or core by autologous dendritic cells expressing hepatitis C virus antigens: potential for vaccine and immunotherapy.
Li W; Krishnadas DK; Li J; Tyrrell DL; Agrawal B
J Immunol; 2006 May; 176(10):6065-75. PubMed ID: 16670315
[TBL] [Abstract][Full Text] [Related]
5. Impaired ability of interferon-alpha-primed dendritic cells to stimulate Th1-type CD4 T-cell response in chronic hepatitis C virus infection.
Miyatake H; Kanto T; Inoue M; Sakakibara M; Kaimori A; Yakushijin T; Itose I; Miyazaki M; Kuzushita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
J Viral Hepat; 2007 Jun; 14(6):404-12. PubMed ID: 17501761
[TBL] [Abstract][Full Text] [Related]
6. Early viraemia clearance during antiviral therapy of chronic hepatitis C improves dendritic cell functions.
Pachiadakis I; Chokshi S; Cooksley H; Farmakiotis D; Sarrazin C; Zeuzem S; Michalak TI; Naoumov NV
Clin Immunol; 2009 Jun; 131(3):415-25. PubMed ID: 19303818
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection.
Encke J; Findeklee J; Geib J; Pfaff E; Stremmel W
Clin Exp Immunol; 2005 Nov; 142(2):362-9. PubMed ID: 16232225
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cell function during chronic hepatitis C virus and human immunodeficiency virus type 1 infection.
Fan Z; Huang XL; Kalinski P; Young S; Rinaldo CR
Clin Vaccine Immunol; 2007 Sep; 14(9):1127-37. PubMed ID: 17634507
[TBL] [Abstract][Full Text] [Related]
9. An autoimmune domain-reduced HCV core gene remains effective in stimulating anti-core cytotoxic T lymphocyte activity.
Liu Y; Zhou W; You C; Zheng H; You H; Liu H; Zhang D; Luo R; Kay HH; Hermonat PL
Vaccine; 2006 Mar; 24(10):1615-24. PubMed ID: 16289277
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy with interferon-α-induced dendritic cells for chronic HCV infection (the results of pilot clinical trial).
Chernykh E; Leplina O; Oleynik E; Tikhonova M; Tyrinova T; Starostina N; Ostanin A
Immunol Res; 2018 Feb; 66(1):31-43. PubMed ID: 29164490
[TBL] [Abstract][Full Text] [Related]
11. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection.
Bain C; Fatmi A; Zoulim F; Zarski JP; Trépo C; Inchauspé G
Gastroenterology; 2001 Feb; 120(2):512-24. PubMed ID: 11159892
[TBL] [Abstract][Full Text] [Related]
12. Virological footprint of CD4+ T-cell responses during chronic hepatitis C virus infection.
Fleming VM; Harcourt G; Barnes E; Klenerman P
J Gen Virol; 2010 Jun; 91(Pt 6):1396-406. PubMed ID: 20107020
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus structural proteins do not prevent human dendritic cell maturation.
Thumann C; Schvoerer E; Abraham JD; Bohbot A; Stoll-Keller F; Aubertin AM; Kieny MP
Gastroenterol Clin Biol; 2008 Jan; 32(1 Pt. 1):59-68. PubMed ID: 18341978
[TBL] [Abstract][Full Text] [Related]
14. Monocytes transduced with lentiviral vectors expressing hepatitis C virus non-structural proteins and differentiated into dendritic cells stimulate multi-antigenic CD8(+) T cell responses.
Jirmo AC; Koya RC; Sundarasetty BS; Pincha M; Yu GY; Lai M; Bakshi R; Schlaphoff V; Grabowski J; Behrens G; Wedemeyer H; Stripecke R
Vaccine; 2010 Jan; 28(4):922-33. PubMed ID: 19931383
[TBL] [Abstract][Full Text] [Related]
15. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
Satoi J; Murata K; Lechmann M; Manickan E; Zhang Z; Wedemeyer H; Rehermann B; Liang TJ
J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603
[TBL] [Abstract][Full Text] [Related]
16. Expression of hepatitis C virus-derived core or NS3 antigens in human dendritic cells leads to induction of pro-inflammatory cytokines and normal T-cell stimulation capabilities.
Li W; Li J; Tyrrell DLJ; Agrawal B
J Gen Virol; 2006 Jan; 87(Pt 1):61-72. PubMed ID: 16361418
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus core protein triggers expansion and activation of CD4(+)CD25(+) regulatory T cells in chronic hepatitis C patients.
Zhai N; Chi X; Li T; Song H; Li H; Jin X; Crispe IN; Su L; Niu J; Tu Z
Cell Mol Immunol; 2015 Nov; 12(6):743-9. PubMed ID: 25531392
[TBL] [Abstract][Full Text] [Related]
18. Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells.
Echeverria I; Pereboev A; Silva L; Zabaleta A; Riezu-Boj JI; Bes M; Cubero M; Borras-Cuesta F; Lasarte JJ; Esteban JI; Prieto J; Sarobe P
Hepatology; 2011 Jul; 54(1):28-37. PubMed ID: 21452282
[TBL] [Abstract][Full Text] [Related]
19. Increased hepatitis C virus (HCV)-specific CD4+CD25+ regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels.
Bolacchi F; Sinistro A; Ciaprini C; Demin F; Capozzi M; Carducci FC; Drapeau CM; Rocchi G; Bergamini A
Clin Exp Immunol; 2006 May; 144(2):188-96. PubMed ID: 16634790
[TBL] [Abstract][Full Text] [Related]
20. TLR ligand-dependent activation of naive CD4 T cells by plasmacytoid dendritic cells is impaired in hepatitis C virus infection.
Yonkers NL; Rodriguez B; Milkovich KA; Asaad R; Lederman MM; Heeger PS; Anthony DD
J Immunol; 2007 Apr; 178(7):4436-44. PubMed ID: 17372001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
